New start-up Uniquity Bio arrived on the scene today with $300 million in funding from Blackstone Life Sciences and a clinical-stage inflammation and immunology drug licensed from MSD. The FDA has ...
Get the best news & discounts for Broadway Shows & beyond.
Element Biosciences’ bid to claim a slice of a DNA sequencing technology market dominated by Illumina has been helped by an impressive $277 million financing round backed by a wide range of investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback